Depletion of HDAC6 was able to abolish the drugs resistance in non-small cell lung cancer (NSCLC) cells (23), whereas, another study reported that HDAC10 stimulated MMR activity by deacetylation of MSH2 at Lys73. Here, HDAC10 is linked to non-small cell lung carcinoma.